Peripheral Vascular Devices Market To Reach $16.90 Billion By 2033

Peripheral Vascular Devices Market Growth & Trends

The global peripheral vascular devices market size is expected to reach USD 16.90 billion by 2033, registering a CAGR of 5.3% from 2025 to 2033, according to a new report by Grand View Research, Inc. The factors driving market growth are the growing prevalence of peripheral arterial disease (pad), increasing clinical trials & studies, technological advancements, and government initiatives. Pharmaceutical companies and medical device manufacturers are increasingly funding clinical trials to explore innovative solutions for peripheral vascular disease PVD. This trend accelerates product development cycles and encourages collaboration between industry stakeholders and academic institutions.

As more studies are initiated, the data generated can significantly help improve these devices' performance and effectiveness. Moreover, regulatory support for increasing clinical trials is anticipated to boost these initiatives, thereby enhancing the development of advanced solutions in the market. For instance, in June 2024, AVS received an Investigational Device Exemption (IDE) from the FDA to conduct a clinical trial for its Pulsatile Intravascular Lithotripsy (PIL) system. The trial will assess the safety and effectiveness of the PIL system in patients with peripheral artery disease. AVS plans to initiate the study across multiple sites, marking a significant step forward in developing less invasive treatment options for patients suffering from calcified vascular conditions. Such efforts by market players, coupled with the developing R&D environment, are expected to drive market growth over the forecast period.

Moreover, the evolving competitive landscape of the peripheral vascular devices market is leading to several initiatives by market players that significantly increase their offerings and availability of these advanced devices to the healthcare sector globally, such as partnerships, expansion, agreements, acquisitions, and others. For instance, in June 2024, Boston Scientific announced an agreement to acquire Silk Road Medical, Inc., specializing in innovative solutions for carotid artery disease. The acquisition, valued at approximately USD 1.1 billion, aims to enhance Boston Scientific's portfolio in vascular intervention and expand its presence in the growing carotid artery market. Such initiatives by the market players to increase their offers, coupled with the growing availability of these devices, are expected to drive market growth over the forecast period.

 Request a free sample copy or view report summary: Peripheral Vascular Devices Market Report

Peripheral Vascular Devices Market Report Highlights

• The peripheral stents segment held a significant share of 21.72% in 2024. The rising government support in the form of funding and approvals is encouraging manufacturers to develop technologically advanced peripheral stents. 

• By application, the peripheral arterial disease (PAD) segment held the largest share of 45.29% in 2024 and is expected to grow at the fastest rate during the forecast period. 

• The hospitals segment held the largest share of 64.37% in 2024 and is expected to grow at the fastest rate during the forecast period. 

• North America peripheral vascular devices market dominated the respective global market with a revenue share of 38.92% in 2024.

Peripheral Vascular Devices Market Segmentation

Grand View Research has segmented the global peripheral vascular devices market on the basis of type, application, and region:

Peripheral Vascular Devices Type Outlook (Revenue USD Million, 2021 - 2033)

• Peripheral Stents

  • Iliac Artery Stents

  • Femoral Artery Stents

  • Carotid Artery Stents

  • Renal Artery Stents

  • Other Peripheral Stents

• PTA Balloons

• Catheters

  • Angiography Catheters

  • Guiding Catheters

  • IVUS/OCT Catheters

• Endovascular Aneurysm Repair Stent Grafts

  • Thoracic Endovascular Aneurysm Stent Grafts

  • Abdominal Endovascular Aneurysm Stent Grafts

• Plaque Modification Devices

  • Atherectomy Devices

  • Thrombectomy Devices

• Peripheral Accessories

  • Guidewires

    • Workhorse Guidewires

    • Specialty Guidewires

    • Extra Support Guidewires

    • Frontline Finesse Guidewires

  • Peripheral Vascular Closure Devices

  • Balloon Inflation Devices

  • Introducer Sheaths

• Inferior Vena Cava Filters

  • Permanent Filters

  • Retrievable Filters

• Hemodynamic Flow Alteration Devices

  • Chronic Total Occlusion Devices

  • Embolic Protection Devices

Peripheral Vascular Devices Application Outlook (Revenue USD Million, 2021 - 2033)

• Peripheral Arterial Disease (PAD)

• Aneurysms

• Venous Diseases

• Others

Peripheral Vascular Devices End Use Outlook (Revenue USD Million, 2021 - 2033)

• Hospitals

• Ambulatory Surgical Centers

• Others

Peripheral Vascular Devices Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Peripheral Vascular Devices Market

• Abbott

• Koninklijke Philips N.V.,

• Edward Lifesciences Corporation

• Medtronic

• Teleflex Incorporated

• Cook

• Cordis (Hellman & Friedman (H&F))

• Boston Scientific Corporation

• W. L. Gore & Associates, Inc.

• Biotronik

• BD

• Terumo Corporation